JP2022553379A5 - - Google Patents
Info
- Publication number
- JP2022553379A5 JP2022553379A5 JP2022523914A JP2022523914A JP2022553379A5 JP 2022553379 A5 JP2022553379 A5 JP 2022553379A5 JP 2022523914 A JP2022523914 A JP 2022523914A JP 2022523914 A JP2022523914 A JP 2022523914A JP 2022553379 A5 JP2022553379 A5 JP 2022553379A5
- Authority
- JP
- Japan
- Prior art keywords
- chain
- tcr
- sequence
- seq
- treg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1915359.2 | 2019-10-23 | ||
| GB201915359A GB201915359D0 (en) | 2019-10-23 | 2019-10-23 | Engineered regulatory t cell |
| PCT/GB2020/052657 WO2021079120A1 (en) | 2019-10-23 | 2020-10-22 | Engineered regulatory t cell |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022553379A JP2022553379A (ja) | 2022-12-22 |
| JP2022553379A5 true JP2022553379A5 (enExample) | 2023-10-19 |
Family
ID=68728329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022523914A Pending JP2022553379A (ja) | 2019-10-23 | 2020-10-22 | 操作された制御性ｔ細胞 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US12692297B2 (enExample) |
| EP (1) | EP4048687A1 (enExample) |
| JP (1) | JP2022553379A (enExample) |
| CN (1) | CN114641487A (enExample) |
| AU (1) | AU2020371991A1 (enExample) |
| CA (1) | CA3154615A1 (enExample) |
| GB (1) | GB201915359D0 (enExample) |
| WO (1) | WO2021079120A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12227756B2 (en) * | 2018-04-18 | 2025-02-18 | Ucl Business Ltd | Engineered regulatory T cell |
| AU2020370033A1 (en) | 2019-10-23 | 2022-06-02 | Ucl Business Ltd | Engineered regulatory T cell |
| JP2025515116A (ja) * | 2022-05-05 | 2025-05-13 | クウェル セラピューティックス リミテッド | 制御性ｔ細胞の抑制活性を維持するための方法 |
| KR20250051662A (ko) * | 2022-08-12 | 2025-04-17 | 아바타 테라퓨틱스 인코포레이티드 | 안정한 조절 t 세포 및 생산 방법 |
| CN120091826A (zh) * | 2022-08-12 | 2025-06-03 | 阿巴塔治疗股份有限公司 | 多发性硬化症的细胞疗法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2825261B1 (fr) | 2001-06-01 | 2003-09-12 | Maco Pharma Sa | Ligne de prelevement du sang placentaire comprenant une poche de rincage |
| US7147626B2 (en) | 2004-09-23 | 2006-12-12 | Celgene Corporation | Cord blood and placenta collection kit |
| EP2050814A1 (en) | 2007-10-17 | 2009-04-22 | Txcell | Compositions for treating multiple sclerosis |
| RU2523058C2 (ru) | 2012-06-29 | 2014-07-20 | Общество с ограниченной ответственностью "Регенекс" | Способ терапии ремиттирующего рассеянного склероза |
| US9693977B2 (en) | 2013-03-15 | 2017-07-04 | President And Fellows Of Harvard College | Method of increasing the quantity of colonic T regulatory cells via G-coupled protein receptor 43 |
| WO2014183056A1 (en) | 2013-05-10 | 2014-11-13 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Design and use of specific regulatory t-cells to induce immune tolerance |
| JP7013240B2 (ja) | 2015-02-16 | 2022-01-31 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | Ｈｅｒ２／Ｎｅｕ （ＥＲＢＢ２）受容体タンパク質に由来する３６９～３７７位エピトープに特異的な完全ヒトＴ細胞受容体 |
| GB201507368D0 (en) | 2015-04-30 | 2015-06-17 | Ucl Business Plc | Cell |
| US20190358258A1 (en) | 2015-10-09 | 2019-11-28 | Robert J. Deans | Methods for enhancing proliferation of t regulatory cells |
| KR20190062505A (ko) * | 2016-10-03 | 2019-06-05 | 주노 쎄러퓨티크스 인코퍼레이티드 | Hpv-특이적 결합 분자 |
| US12227756B2 (en) * | 2018-04-18 | 2025-02-18 | Ucl Business Ltd | Engineered regulatory T cell |
| AU2020370033A1 (en) | 2019-10-23 | 2022-06-02 | Ucl Business Ltd | Engineered regulatory T cell |
-
2019
- 2019-10-23 GB GB201915359A patent/GB201915359D0/en not_active Ceased
-
2020
- 2020-10-22 WO PCT/GB2020/052657 patent/WO2021079120A1/en not_active Ceased
- 2020-10-22 US US17/771,465 patent/US12692297B2/en active Active
- 2020-10-22 CA CA3154615A patent/CA3154615A1/en active Pending
- 2020-10-22 EP EP20800252.7A patent/EP4048687A1/en active Pending
- 2020-10-22 CN CN202080074667.XA patent/CN114641487A/zh active Pending
- 2020-10-22 AU AU2020371991A patent/AU2020371991A1/en not_active Abandoned
- 2020-10-22 JP JP2022523914A patent/JP2022553379A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021520831A5 (enExample) | ||
| JP2022553540A5 (enExample) | ||
| KR100899970B1 (ko) | Ｔ-세포 에피토프의 동정 방법 및 감소된 면역원성을 갖는분자의 제조를 위한 용도 | |
| JP2022050400A5 (enExample) | ||
| JP2021520198A5 (enExample) | ||
| JP2020529830A5 (enExample) | ||
| JP2022502371A5 (enExample) | ||
| JP4294596B2 (ja) | 糸球体腎炎および他の炎症性疾患の治療のための組成物および方法 | |
| CN105492610B (zh) | 特异性结合分子的合成文库 | |
| JP2024522357A5 (enExample) | ||
| BR112022001923A2 (pt) | Proteína de ligação ao antígeno, ácido nucleico isolado, célula hospedeira recombinante, composição farmacêutica, método de produção da proteína de ligação ao antígeno | |
| JP2023025108A5 (enExample) | ||
| JP2019511222A5 (enExample) | ||
| JP2019536430A5 (enExample) | ||
| JP2021526816A5 (enExample) | ||
| JP2018510881A5 (enExample) | ||
| JP2020511115A5 (enExample) | ||
| TW201827460A (zh) | 改善配對的ｔ細胞受體 | |
| KR960703014A (ko) | Mhc 분자 hla-c-클론 10과 복합체를 형성하는 분리된 펩티드 및 그것의 사용(isolated peptides which form complexes with mhc molecule hla-c-clone 10 and uses thereof) | |
| CZ328895A3 (en) | Monoclonal antibody, fragment thereof, process for preparing such monoclonal antibody and pharmaceutical composition containing thereof | |
| JPWO2020059847A5 (enExample) | ||
| JP2020502996A5 (enExample) | ||
| JP2023505492A5 (enExample) | ||
| JP2023524788A5 (enExample) | ||
| TW201828977A (zh) | 新穎t細胞受體以及使用彼之免疫療法 |